News
Experts are warning about soaring new cases of a deadly bacteria which leaves patients scared with the ‘worst diarrhoea ever’ ...
Clostridioides difficile/Clostridium difficile (C. diff) is a bacterial infection and is the most common cause of healthcare-associated diarrhea. C. diff has two distinct presentations, primary ...
Doctors have warned that more must be done to tackle the rise of a highly contagious bacteria. More than one in ten cases of ...
A new study on Clostridioides difficile infections finds that choosing an alternative antibiotic for high-risk patients with pneumonia can reduce infection risk.
One of the most common health care-associated infections spreads within intensive care units (ICUs) more than three times more than previously thought, new research has found.
The case could represent the first known instance of cat-to-human transmission of recurrent C. diff, though more research is needed to confirm this risk.
The antibiotic vancomycin, recommended as first-line treatment for infection caused by the deadly superbug C. difficile (C. diff), may not be living up to its promise, according to new research.
Researchers at the University of Iowa found that adding high-dose IV vitamin C to chemotherapy helped increase survival in pancreatic cancer patients. Study author Dr. Cullen and oncologists discuss.
A new study suggests that the leading antibiotic used to fight Clostridioides difficile, vancomycin, may be losing potency against this killer.
The pathogen C. diff—the most common cause of health care-associated infectious diarrhea—can use a compound that kills the human gut's resident microbes to survive and grow, giving it a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results